Dossier
Loblaw
Coverage of Loblaw in the Nexus archive.
- Loblaw boosts profit on generic GLP-1 drug sales, bargain hunting shoppers
Loblaw, Canada's largest grocer, is boosting profits by focusing on generic GLP-1 drug sales, which have seen a 40 per cent year-to-date sales increase. The company attributes this growth to bargain-hunting shoppers and a new business strategy.
- Canada Approves EQB Takeover of Loblaw’s Mass-Market Banking Arm
Canada has approved the takeover of Loblaw's mass-market banking arm by EQB. This move is significant in the Canadian financial sector. The details of the deal have not been disclosed.